Clinical Trial Site is a clinical research site located in Seattle, Washington, United States 98195.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Clinical Trial Site has participated in 11 clinical trials with 4 currently active.
Therapeutic areas: Acute Hepatic Porphyria, Acute Intermittent Porphyria, Porphyria, Acute Intermittent.
Sponsors: Alnylam Pharmaceuticals, Amgen, LogicBio Therapeutics, Inc.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Clinical Trial Site has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Clinical Trial Site has 11 clinical trials on record, with 4 currently active. Their work covers Acute Hepatic Porphyria, Acute Intermittent Porphyria, Porphyria, Acute Intermittent.
Yes — Clinical Trial Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.